SMTL ID : 2vjz.1

Crystal structure form ultalente insulin microcrystals

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

hetero-6-6-mer

Ligands

6 x ZN: ZINC ION(Non-covalent)

ZN.1: 8 residues within 4Å: Chain B: H.10 Chain F: H.10 Chain J: H.10 Ligands: CL.2, ZN.7, CL.8, ZN.13, CL.14 3 PLIP interactions: 1 interactions with chain B, 1 interactions with chain F, 1 interactions with chain J Metal complexes: B:H.10, F:H.10, J:H.10 ZN.4: 4 residues within 4Å: Chain D: H.10 Chain L: H.5 Ligands: CL.5, CL.6 2 PLIP interactions: 1 interactions with chain L, 1 interactions with chain D Metal complexes: L:H.5, D:H.10 ZN.7: 8 residues within 4Å: Chain B: H.10 Chain F: H.10 Chain J: H.10 Ligands: ZN.1, CL.2, CL.8, ZN.13, CL.14 3 PLIP interactions: 1 interactions with chain B, 1 interactions with chain F, 1 interactions with chain J Metal complexes: B:H.10, F:H.10, J:H.10 ZN.10: 4 residues within 4Å: Chain D: H.5 Chain H: H.10 Ligands: CL.11, CL.12 2 PLIP interactions: 1 interactions with chain H, 1 interactions with chain D Metal complexes: H:H.10, D:H.5 ZN.13: 8 residues within 4Å: Chain B: H.10 Chain F: H.10 Chain J: H.10 Ligands: ZN.1, CL.2, ZN.7, CL.8, CL.14 3 PLIP interactions: 1 interactions with chain B, 1 interactions with chain F, 1 interactions with chain J Metal complexes: B:H.10, F:H.10, J:H.10 ZN.16: 4 residues within 4Å: Chain H: H.5 Chain L: H.10 Ligands: CL.17, CL.18 2 PLIP interactions: 1 interactions with chain H, 1 interactions with chain L Metal complexes: H:H.5, L:H.10

12 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 8 residues within 4Å: Chain B: H.10 Chain F: H.10 Chain J: H.10 Ligands: ZN.1, ZN.7, CL.8, ZN.13, CL.14 Ligand excluded by PLIP CL.3: 4 residues within 4Å: Chain B: E.13 Chain H: H.10, E.13, A.14 Ligand excluded by PLIP CL.5: 7 residues within 4Å: Chain C: L.16 Chain D: H.10, L.11, A.14 Chain L: H.5 Ligands: ZN.4, CL.6 Ligand excluded by PLIP CL.6: 7 residues within 4Å: Chain D: H.10 Chain J: E.13, Y.16, L.17 Chain L: H.5 Ligands: ZN.4, CL.5 Ligand excluded by PLIP CL.8: 8 residues within 4Å: Chain B: H.10 Chain F: H.10 Chain J: H.10 Ligands: ZN.1, CL.2, ZN.7, ZN.13, CL.14 Ligand excluded by PLIP CL.9: 4 residues within 4Å: Chain F: E.13 Chain L: H.10, E.13, A.14 Ligand excluded by PLIP CL.11: 7 residues within 4Å: Chain D: H.5 Chain G: L.16 Chain H: H.10, L.11, A.14 Ligands: ZN.10, CL.12 Ligand excluded by PLIP CL.12: 7 residues within 4Å: Chain B: E.13, Y.16, L.17 Chain D: H.5 Chain H: H.10 Ligands: ZN.10, CL.11 Ligand excluded by PLIP CL.14: 8 residues within 4Å: Chain B: H.10 Chain F: H.10 Chain J: H.10 Ligands: ZN.1, CL.2, ZN.7, CL.8, ZN.13 Ligand excluded by PLIP CL.15: 4 residues within 4Å: Chain D: H.10, E.13, A.14 Chain J: E.13 Ligand excluded by PLIP CL.17: 7 residues within 4Å: Chain H: H.5 Chain K: L.16 Chain L: H.10, L.11, A.14 Ligands: ZN.16, CL.18 Ligand excluded by PLIP CL.18: 7 residues within 4Å: Chain F: E.13, Y.16, L.17 Chain H: H.5 Chain L: H.10 Ligands: ZN.16, CL.17 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wagner, A. et al., Crystal Structure of Ultralente-A Microcrystalline Insulin Suspension. Proteins (2009)

Release Date

2008-09-16

Peptides

INSULIN A CHAIN: ACEGIK
INSULIN B CHAIN: BDFHJL

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
C

E
A

G
C

I
A

K
C

B
B

D
D

F
B

H
D

J
B

L
D

INSULIN A CHAIN

INSULIN B CHAIN

Related Entries With Identical Sequence